Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Knowing when to adjust is key. This piece outlines clear signals that your Zero Based Budget needs updating and the next steps to take.
19,541 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A sharp spike in local impact fees in Manatee County jeopardizes Live Local housing projects as developers and lawmak...
Microsoft’s latest earnings show a resilient AI-powered expansion, with a $627 billion backlog and a near $37 billion...
Ultra-wealth households are paying premium to private staff amid a tightening labor market, with some packages includ...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Meta Platforms stock surged this week as investors cheered hints of in-house AI chips and bigger cloud capacity. We b...
Amazon trimmed 16,000 jobs in early 2026, even as CEO Jeff Bezos warned AI could create a labor shortage. The clash b...
Microsoft Copilot AI signals a bold XRP rally by year-end 2026, driven by real-world catalysts and on-chain activity....
JPMorgan Chase posted a strong quarterly beat, led by a surge in equity-markets revenue and higher net interest incom...
What separates a thriving growth story from a market-ready bubble? This guide breaks down concrete signals, offers a ...
Investors are buzzing about what happening with quantumscape. This article breaks down the core catalysts, risks, and...